Abstract: The present invention relates to a pharmaceutical formulation comprising (i) a therapeutically effective amount of a bispecific protein comprising a soluble T cell receptor (TCR) and an scFV; and (ii) a surfactant. The w/w ratio of surfactant to protein is in the range of 0.75:1 to 1.5:1. The formulation may further comprise a bulking agent and/or a stabiliser. A further pharmaceutical formulation comprises (i) a therapeutically effective amount of a bispecific protein comprising a soluble T cell receptor (TCR) and an scFV; (ii) a bulking agent; and (iii) a stabiliser. The w/w ratio of stabiliser to bulking agent may be greater than 1:1.

Abstract: Systems, apparatuses and methods for monitoring wireless communication performance. A fleet of moving vehicles equipped with communication devices communicate data call records, including a geographic location of the vehicle when the communication was attempted, to a central office. Indications of successful and unsuccessful call record communications attempts are aggregated by geographic area using the geographic location data from the vehicles. Call success rate levels for the geographic areas are determined based on the aggregated indications of successful and unsuccessful call record communication attempts. These levels may be presented on geographical maps or otherwise, and/or used for network analysis purposes.

Abstract: Systems, apparatuses and methods for monitoring wireless communication performance. A fleet of moving vehicles equipped with communication devices communicate data call records, including a geographic location of the vehicle when the communication was attempted, to a central office. Indications of successful and unsuccessful call record communications attempts are aggregated by geographic area using the geographic location data from the vehicles. Call success rate levels for the geographic areas are determined based on the aggregated indications of successful and unsuccessful call record communication attempts. These levels may be presented on geographical maps or otherwise, and/or used for network analysis purposes.

Abstract: An aircraft flight surface control system and method simultaneously provides the benefits of both an active/active system architecture and in active/standby system architecture. The system is preferably implemented using hydraulic actuator assemblies and electromechanical actuator assemblies coupled to the same flight control surface. During normal system operations the electromechanical actuator assemblies are energized to supply a relatively minimal force to associated flight control surfaces. In effect, the electromechanical actuators, although energized, may be pulled along by the associated hydraulic actuator assemblies, until needed. Thus, the electromechanical actuator assemblies are controlled in a manner that closely resembles the active/standby architecture.